CVS HEALTH Corp·4

Feb 14, 5:14 PM ET

Havanec Laurie P. 4

4 · CVS HEALTH Corp · Filed Feb 14, 2024

Insider Transaction Report

Form 4
Period: 2024-02-12
Havanec Laurie P.
EVP and Chief People Officer
Transactions
  • Award

    Common Stock

    2024-02-12+16,81737,203 total
Holdings
  • Common Stock (Restricted)

    14,678
  • Stock Option

    Exercise: $74.30From: 2022-04-01Exp: 2031-04-01Common Stock (27,643 underlying)
    27,643
  • Stock Option

    Exercise: $101.09From: 2023-04-01Exp: 2032-04-01Common Stock (21,829 underlying)
    21,829
  • Stock Option

    Exercise: $74.31From: 2024-04-01Exp: 2033-04-01Common Stock (51,959 underlying)
    51,959
Footnotes (4)
  • [F1]Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on April 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 12, 2024.
  • [F2]Option became exercisable in four equal installments, commencing 4/1/2022.
  • [F3]Option became exercisable in four equal installments, commencing 4/1/2023.
  • [F4]Option becomes exercisable in four equal installments, commencing 4/1/2024.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT